Sellbyville, DE -- (SBWire) -- 11/08/2018 --Global Cancer Diagnostics Market set to exceed USD 156 billion by 2024; according to a new research report by Global Market Insights.
Technological advancements in target disease screening tests along with numerous initiatives undertaken by WHO and domestic government to reduce disease prevalence will positively impact the global market growth. Growing adoption of western culture, unhealthy food habits and physical inactivity has escalated number of people suffering from various chronic diseases such as cancer.
Request for a sample of this research report @ https://www.gminsights.com/request-sample/detail/2406
Company profiled in this report based on Business overview, Financial data, Product landscape, Strategic outlook & SWOT analysis:
- Siemens Healthineers
- Agilent Technologies
- BD
- bioMérieux
- Bio-Rad Laboratories
- Hologic, Inc.
- Danaher Corporation
- QIAGEN
- Alere Inc.
- Janssen Diagnostics
- Myriad Genetics
- Biocartis
- Sysmex Corporation
- Cancer Genetics, Inc.
- Kalila Medical
- Biocare Medical
Cancer imaging held largest market share in 2016 and is anticipated to follow similar trend during the forecast period. Availability of non-invasive rapid imaging modalities such as magnetic resonance imaging (MRI) along with several applications of imaging in disease management from diagnosis to treatment will drive cancer imaging market over the forecast period. Imaging is also used in assisting radiography and surgery coupled with identification of structural and cancer related changes.
Liquid biopsy market size will witness robust growth over the forecast timeframe. Growing demand for minimal invasive procedures, rising prevalence of cancer along with availability of funding for liquid biopsy R&D will drive industry growth over the coming years.
Make an inquiry for purchasing this report @ https://www.gminsights.com/inquiry-before-buying/2406
U.S. dominated cancer diagnostics market in 2016 and is expected to grow with more than 8.0% CAGR. Growing geriatric population, high cancer prevalence rate, and rising awareness about early disease diagnosis and prevention will drive U.S. market. Growing healthcare expenditure by government as well as individual coupled with favourable reimbursement policies will positively impact market growth.
Cancer Diagnostics Market by Application
- Tumor Biomarkers Tests
- Imaging
- Ultrasound and radiology
- Mammography
- MRI scan
- PET scan
- CT scan
- SPECT & others
- Biopsy
- Liquid biopsy
- Immunohistochemistry
- In Situ hybridization
2018 Cancer Diagnostics Market Outlook: Key Players: Siemens Healthineers, Agilent Technologies, BD, bioMérieux, Bio-Rad Laboratories, Hologic, Inc., Danaher Corporation
Cancer Diagnostics Market surge to hit USD 156 billion by 2024